Explore more publications!
Sao Tome and Principe Tech
Got News to Share?

Sao Tome and Principe Tech: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sao Tome and Principe Tech.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 27, 2026

Cellectis présente sa plateforme d’édition épigénétique pour éteindre des gènes sans modifier l’ADN, lors du congrès annuel de l’ASGCT
Apr. 27, 2026

Cellectis présente sa plateforme d’édition épigénétique pour éteindre des gènes sans modifier l’ADN, lors du congrès annuel de l’ASGCT

Indeterminate GlobeNewswire
Umoja Biopharma Announces Unveiling of UB-VV500 in Upcoming Poster Presentation at the American Society of Gene & Cell Therapy Annual Meeting
Apr. 27, 2026

Umoja Biopharma Announces Unveiling of UB-VV500 in Upcoming Poster Presentation at the American Society of Gene & Cell Therapy Annual Meeting

Indeterminate GlobeNewswire
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
Apr. 27, 2026

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

Indeterminate GlobeNewswire
Rgenta Therapeutics Announces Two Oral Presentations Highlighting Proprietary RSwitch Technology at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting
Apr. 27, 2026

Rgenta Therapeutics Announces Two Oral Presentations Highlighting Proprietary RSwitch Technology at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting

Indeterminate GlobeNewswire
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting
Apr. 27, 2026

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 29th Annual Meeting

Indeterminate GlobeNewswire
Addition Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting
Apr. 27, 2026

Addition Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy (ASGCT) 29th Annual Meeting

Indeterminate GlobeNewswire
Oruka Therapeutics Announces Proposed $500 Million Underwritten Public Offering
Apr. 27, 2026

Oruka Therapeutics Announces Proposed $500 Million Underwritten Public Offering

Indeterminate GlobeNewswire
Enovix to Report First Quarter 2026 Financial Results on May 13, 2026
Apr. 27, 2026

Enovix to Report First Quarter 2026 Financial Results on May 13, 2026

Indeterminate GlobeNewswire
Rigetti Computing to Report First Quarter 2026 Financial Results and Host Conference Call on May 11, 2026
Apr. 27, 2026

Rigetti Computing to Report First Quarter 2026 Financial Results and Host Conference Call on May 11, 2026

Indeterminate GlobeNewswire
Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions
Apr. 27, 2026

Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions

Indeterminate GlobeNewswire
Snail Games USA Expands Publishing Portfolio with the Launch of Above The Snow
Apr. 27, 2026

Snail Games USA Expands Publishing Portfolio with the Launch of Above The Snow

Indeterminate GlobeNewswire
Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production
Apr. 27, 2026

Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production

Indeterminate GlobeNewswire
Asure Software Launches AsureWorks, a Done-for-You Payroll and HR Service for Employers
Apr. 27, 2026

Asure Software Launches AsureWorks, a Done-for-You Payroll and HR Service for Employers

Indeterminate GlobeNewswire
Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors
Apr. 27, 2026

Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors

Indeterminate GlobeNewswire
Intellia Announces Proposed Public Offering of Common Stock
Apr. 27, 2026

Intellia Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
VisionSys AI Inc. Announces Proposed $90 Million Strategic Investment at $1.50 Per Share
Apr. 27, 2026

VisionSys AI Inc. Announces Proposed $90 Million Strategic Investment at $1.50 Per Share

Indeterminate GlobeNewswire
EXL recognized as 2025 Genesys New Partner of the Year
Apr. 27, 2026

EXL recognized as 2025 Genesys New Partner of the Year

Indeterminate GlobeNewswire
UNO OS Launches AI-Driven Operating System to Help Businesses Scale Efficiently, Founded by Siloh Moses
Apr. 27, 2026

UNO OS Launches AI-Driven Operating System to Help Businesses Scale Efficiently, Founded by Siloh Moses

Indeterminate GlobeNewswire
Ministry Brands Launches Embedded Payments Powered by AvidXchange
Apr. 27, 2026

Ministry Brands Launches Embedded Payments Powered by AvidXchange

Indeterminate GlobeNewswire
AB Science announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditors
Apr. 27, 2026

AB Science announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditors

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions